NanoCytomics mission is to provide tests that will detect cancer in the early stages when treatments can be more effective at improving patient survival rates. We will do this through the use of our proprietary PWS technology platform, which provides highly accurate, low cost, non invasive pre-screening tests to help physicians identify patients most likely to benefit from more invasive testing.
DDW Tracks Technologies and Procedural Innovations
Does your company only service US attendees? No